News & Insights
Welcome to Bellberry’s blog. Here we publish commentary, updates, feature posts, and thought leadership on research ethics, regulation, participant experience, and system change. Discover what’s happening across the research and ethics landscape in Australia and beyond.
Bellberry at AAHMS Annual Scientific Meeting 2020
The 2020 Australian Academy of Health and Medical Sciences (AAHMS) Annual Scientific Meeting will be held online this year enabling it to be open to both the research community and the wider public. The meeting is spread over two days and aims to explore the latest developments for precision medicine and emerging science around prevention […]
Read More
ARCS Virtual Summit 2020
The 2020 ARCS Virtual Summit brings together industry, regulator, academia and researchers to educate, network and unite in a time of change. It will provide essential and timely information in each of the key educational areas – particularly as we traverse the issues associated with the COVID-19 pandemic as well other local and international issues. […]
Read More
Christmas and New Year 2020-21 Meeting & Submission Dates
The last meeting of 2020 will be held on Wed 23 December with a submission deadline date of Wed 9 December. The first meeting of 2021 will be on Wed 6 January with a submission deadline of Wed 16 December. The Bellberry office will be closed from COB on Thurs 24 December until Mon 4 […]
Read More
HREC Officer Vacancies
Bellberry Limited is a private, national, independent, not-for-profit organisation, recognised in the McKeon review as a best practice example, supporting the Australian health research community through professionally managed Human Research Ethics Committees (HRECs) serving researchers across Australia. Due to our continued growth, we are currently recruiting for: HREC Officers Officers provide high-level support to the […]
Read More
Batch submissions
As part of our continuous improvement process, Bellberry has introduced a Batch Processing pathway. This pathway aims to ease the burden on sites and sponsors. The batch submission pathway enables: a single submission applicable across multiple studies and/or multiple sites, a single submission applicable to one site when the site/sponsor is unable to enter the […]
Read More
CT:IQ: Supporting the Implementation of eConsent in Australia
CT:IQ is pleased to launch a series of use cases illustrating successful implementation of eConsent in Australia, aimed to be used as a guide for researchers and HRECs seeking to develop and implement eConsent. In 2019, Chrysalis Advisory, on behalf of CT:IQ, undertook an investigation of stakeholder opinions about the benefits, risks and critical success factors […]
Read More
eProtocol Registrations Change
Bellberry is committed to ensuring the privacy and security for users of our service. In light of recent government announcements warning of increases in cybersecurity attacks, Bellberry has assessed its current processes relating to eProtocol registrations and have made the following changes to strengthen our current security procedures. All new eProtocol registrations will be required […]
Read More
PRAXIS Webinar: What does the new face of Clinical Trials look like?
Disruption, adaption and adoption The COVID-19 pandemic has rapidly transformed much of the clinical trials and associated medical device, pharmaceutical, and vaccine industries in Australia and internationally. What’s next for the world of clinical research as we learn to adapt to the changes which are likely to remain with us long term as a result […]
Read More
COVID-19 FAQ
COVID-19 FAQ As Bellberry’s position has changed significantly since 2020, please direct your COVID-19 queries to bellberry@belberry.com.au. We’re here to help.
Read More
Progress Reporting Change
Based on feedback from sites and sponsors, and in our aim for continuous improvement, Bellberry has made further attempts to streamline progress reporting. The change in reporting will make it easier for sites and sponsors to control and manage the due dates for progress reports and consolidates the two processes of progress reports and extension […]
Read More
Bellberry receives Australian first recognition
Bellberry awarded AAHRPP accreditation Bellberry has become the first organisation in Australia to achieve international accreditation for excellence and ethically sound processes in running Human Research Ethics Committees (HRECs). The recognition has come from the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is based in the USA. The AAHRPP site accreditation team […]
Read More
Clinical Trials in the time of COVID-19: A case study
Perth based not-for-profit clinical trial facility, Linear, got early warning on the seriousness of COVID-19 thanks to a staff member who was visiting China and staying in the province next to Hubei. The trained nurse who is the Head of China Business Development for Linear, not only played a crucial role in alerting the organisation […]
Read More
Beyond COVID-19: A solution focussed forum
ACTA, PRAXIS, ARCS and CT:IQ collaborate to host clinical trials online forum launching on International Clinical Trials Day, 20 May 2020 Australian Clinical Trials Alliance (ACTA), PRAXIS Australia, ARCS Australia and CT:IQ have come together to create Beyond COVID-19: a solution-focussed forum after identifying a need for the clinical trial sector to collaborate and share information. […]
Read More
Challenges in valuing and paying for combination regimens in oncology
Report of an international workshop convened by Bellberry, held on November 18-20, in Sydney, Australia In November 2019 Bellberry were delighted to host the “Challenges of Valuing and paying for Combination Therapies in Oncology” international workshop in Sydney. This event brought together over 50 experts from around the world from a range of stakeholder groups […]
Read More
COVID-19 Update: 1 May 2020
To assist and guide you through this challenging time, Bellberry will continue to gather, distil and deliver the latest information relevant to the oversight of clinical trials during the COVID-19 pandemic. We will be providing new information as it becomes available. Click here to access the latest information https://bellberry.com.au/covid-19-updates/
Read More
Human Research Ethics Committees
Discover how Bellberry's committees operate and maintain the highest ethical standards in research.
Learn More
Monitoring & Quality
Learn about Bellberry's continuous improvement and oversight processes that ensure accountability.
Learn More
Grant Activities
See how Bellberry reinvests in research education and participant-focused initiatives.
Learn More